Exclusivity rights currently prevent any generic versions of Bepreve from being produced. Once these rights expire, provided there are no other outstanding patents or lawsuits, companies are expected to begin making a generic version. Bepotastine besilate is the active ingredient in the drug -- this is not the same thing as a generic version.
Can I Buy Generic Bepreve?Bepreve™ (bepotastine besilate) is a prescription eye drop used to treat eye allergies (known medically as allergic conjunctivitis). It belongs to a group of medications known as antihistamines and is approved for use in individuals as young as two years of age.
Bepreve is manufactured by Bausch & Lomb, Inc., for ISTA Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic Bepreve from being manufactured in the United States.
When Will a Generic Version of Bepreve Be Available?
Bausch & Lomb holds the exclusive rights to market Bepreve until at least 2014. This is the earliest predictable date that a generic version could become available. However, other circumstances could come up to extend or shorten the exclusivity period. This could include such things as lawsuits or other patents for new Bepreve uses.
Once the patent expires, several companies likely will begin manufacturing a generic Bepreve drug.
Is Bepotastine a Generic Bepreve?
No -- bepotastine besilate is the active ingredient in Bepreve, but is not a generic version of it. This can be confusing because the active ingredient of any drug is often referred to as the "generic name." The generic name is different from a generic version of a medicine.
In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.